Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its availability have become key topics for patients and healthcare practitioners. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant barrier to many.